Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma
Clinical trial NCT02061449 · TERMINATED
Trial details
- NCT number
- NCT02061449
- Sponsor
- NYU Langone Health
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2018-11-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.